138 related articles for article (PubMed ID: 15837050)
1. Familial medullary thyroid cancer: clinical aspects and prognosis.
Hyer SL; Newbold K; Harmer C
Eur J Surg Oncol; 2005 May; 31(4):415-9. PubMed ID: 15837050
[TBL] [Abstract][Full Text] [Related]
2. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
Austin JR; el-Naggar AK; Goepfert H
Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
8. [Decision making in postoperative incidentally found small C-cell-carcinoma].
Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.
Sakorafas GH; Friess H; Peros G
Endocr Relat Cancer; 2008 Dec; 15(4):871-84. PubMed ID: 19015274
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival rates in young patients with thyroid carcinoma.
Kowalski LP; Gonçalves Filho J; Pinto CA; Carvalho AL; de Camargo B
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):746-9. PubMed ID: 12874076
[TBL] [Abstract][Full Text] [Related]
11. Micromedullary thyroid cancer: how micro is truly micro?
Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
14. Hereditary medullary thyroid carcinoma in patients greater than 50 years old.
Quayle FJ; Benveniste R; DeBenedetti MK; Wells SA; Moley JF
Surgery; 2004 Dec; 136(6):1116-21. PubMed ID: 15657564
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of survival in medullary cancers of the thyroid. Apropos of 51 cases. Clinical, biochemical and immunocytochemical study].
Goudet P; Rogissart F; Petit JM; Vaillant G; Durnerin I; Fraisse J; Justrabo E; Verges B; Cougard P
Ann Chir; 1996; 50(1):23-9. PubMed ID: 8734273
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of familial medullary thyroid carcinoma].
Palestini N; Tagliabue M; Cestino L; Farnetti A; Rossetto R; Vendrame A
Minerva Chir; 2003 Dec; 58(6):801-9. PubMed ID: 14663408
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
[TBL] [Abstract][Full Text] [Related]
20. [The role of external radiotherapy in the treatment of medullary carcinoma of the thyroid].
Costa MA; Sousa O; Azevedo I; Castro C; Fernandes T; Vieira E
Acta Med Port; 1998 Jun; 11(6):539-42. PubMed ID: 9773532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
